Tapering Corticosteroids Reduces Infections in Severe Alcohol-Associated Hepatitis
New research highlights the safety and effectiveness of tapered corticosteroid dosing in managing severe alcohol-associated hepatitis.
Topline:
A recent multicenter randomized trial shows that tapering corticosteroids for severe alcohol-associated hepatitis reduces infection rates and hospitalizations without significantly affecting survival outcomes compared to fixed-dose regimens.
Study Details
Severe alcohol-associated hepatitis (SAH) is a life-threatening condition with limited treat…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.